BIOX III— 510(k) K820110

Substantially Equivalent

Biox Technology, Inc.

FDA 510(k) clearance K820110 for BIOX III, Substantially Equivalent on 1982-02-12. Applicant: Biox Technology, Inc..

Clearance details

Applicant: Biox Technology, Inc.
Product code: Code DQA
Advisory panel: Cardiovascular
Date received: 1982-01-15
Decision date: 1982-02-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DQA

product code DQA

Death: 66
Malfunction: 2,867
Other: 1
Total: 2,934

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.